These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21611963)

  • 1. Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow.
    Jacome-Galarza CE; Lee SK; Lorenzo JA; Aguila HL
    J Bone Miner Res; 2011 Jun; 26(6):1207-16. PubMed ID: 21611963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
    Weir EC; Lowik CW; Paliwal I; Insogna KL
    J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The generation of highly enriched osteoclast-lineage cell populations.
    Quinn JM; Whitty GA; Byrne RJ; Gillespie MT; Hamilton JA
    Bone; 2002 Jan; 30(1):164-70. PubMed ID: 11792580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.
    Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG
    Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-3 plays dual roles in osteoclastogenesis by promoting the development of osteoclast progenitors but inhibiting the osteoclastogenic process.
    Hong H; Shi Z; Qiao P; Li H; McCoy EM; Mao P; Xu H; Feng X; Wang S
    Biochem Biophys Res Commun; 2013 Nov; 440(4):545-50. PubMed ID: 24103757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.
    Lee SK; Kalinowski JF; Jastrzebski SL; Puddington L; Lorenzo JA
    Endocrinology; 2003 Aug; 144(8):3524-31. PubMed ID: 12865334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone.
    De Vries TJ; Schoenmaker T; Aerts D; Grevers LC; Souza PP; Nazmi K; van de Wiel M; Ylstra B; Lent PL; Leenen PJ; Everts V
    J Cell Physiol; 2015 Jan; 230(1):210-25. PubMed ID: 24962140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone.
    Okada Y; Montero A; Zhang X; Sobue T; Lorenzo J; Doetschman T; Coffin JD; Hurley MM
    J Biol Chem; 2003 Jun; 278(23):21258-66. PubMed ID: 12665515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse osteoclastogenesis of bone marrow from mandible versus long bone.
    Chaichanasakul T; Kang B; Bezouglaia O; Aghaloo TL; Tetradis S
    J Periodontol; 2014 Jun; 85(6):829-36. PubMed ID: 24003963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.
    Tao H; Okamoto M; Nishikawa M; Yoshikawa H; Myoui A
    PLoS One; 2011; 6(8):e23199. PubMed ID: 21886782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
    Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
    Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells.
    Fuller K; Owens JM; Chambers TJ
    J Endocrinol; 1998 Sep; 158(3):341-50. PubMed ID: 9846163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.
    Woo JT; Nakagawa H; Notoya M; Yonezawa T; Udagawa N; Lee IS; Ohnishi M; Hagiwara H; Nagai K
    Biol Pharm Bull; 2004 Apr; 27(4):504-9. PubMed ID: 15056855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation in an LXRβ-dependent mechanism.
    Remen KM; Henning P; Lerner UH; Gustafsson JÅ; Andersson G
    J Biol Chem; 2011 Sep; 286(38):33084-94. PubMed ID: 21784849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms.
    Granholm S; Lundberg P; Lerner UH
    J Endocrinol; 2007 Dec; 195(3):415-27. PubMed ID: 18000304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells.
    Schulze J; Bickert T; Beil FT; Zaiss MM; Albers J; Wintges K; Streichert T; Klaetschke K; Keller J; Hissnauer TN; Spiro AS; Gessner A; Schett G; Amling M; McKenzie AN; Horst AK; Schinke T
    J Bone Miner Res; 2011 Apr; 26(4):704-17. PubMed ID: 20939024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of multiple osteoclast precursor populations in murine bone marrow.
    Jacquin C; Gran DE; Lee SK; Lorenzo JA; Aguila HL
    J Bone Miner Res; 2006 Jan; 21(1):67-77. PubMed ID: 16355275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.